Genscript Biotech Co. (OTCMKTS:GNNSF) Sees Large Decline in Short Interest

Genscript Biotech Co. (OTCMKTS:GNNSF) was the recipient of a large decline in short interest in the month of October. As of October 15th, there was short interest totalling 5,624,400 shares, a decline of 11.9% from the September 30th total of 6,386,400 shares. Based on an average daily volume of 400 shares, the short-interest ratio is currently 14,061.0 days.

Genscript Biotech Stock Performance

Shares of OTCMKTS:GNNSF traded up C$0.04 during mid-day trading on Thursday, hitting C$1.54. The company had a trading volume of 1,750 shares, compared to its average volume of 71,307. The firm has a fifty day moving average price of C$1.44 and a 200 day moving average price of C$1.40. Genscript Biotech has a one year low of C$1.05 and a one year high of C$3.20.

Genscript Biotech Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.